Precursor Lymphoid Neoplasm — Trials

Precursor Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 567
Recruiting: 344
Ph III recruiting: 27
Growth YoY: −11.9%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (286)

clinicaltrialsPublishedShowing 201–250 of 778 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05464836	Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL	terminated	Phase 2	2	M.D. Anderson Cancer CenterOTHER	1	Nov 26, 2025	clinicaltrials
NCT06316427	Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies	recruiting	Phase 1 / Phase 2	80	Beijing GoBroad HospitalOTHER	1	Nov 26, 2025	clinicaltrials